Ro vs Mate

Choose Mate if: You want a drug-free option and would rather skip the prescription entirely. Mate Ignite runs $45/mo cash-pay as a supplement, and Mate Endurance covers premature ejaculation at $48/mo. Be aware this is not the budget pick on price alone: Ro's prescription ED plans start at $48/mo and its premature ejaculation options at $16/mo. Mate lists no hair loss treatment, and as a supplement its formula has not been reviewed by the FDA for effectiveness.

Choose Ro if: You have insurance coverage (dramatically reduces costs through copays and prescription benefits making Ro CHEAPER than Mate for insured patients), seek telehealth platform addressing ED, hair loss, weight management, dermatology, primary care, or multiple conditions; prioritize proven scale (7+ years of operating history); need medication options including brand-name Viagra/Cialis and GLP-1 weight loss; value superior medical team quality and ongoing physician support; want an established platform that has stuck around and keeps medication in stock; or require multi-specialty care coordination across concurrent health conditions.

Bottom line: Mate and Ro are not two versions of the same service. Ro is prescription telehealth; Mate is a drug-free supplement brand. Ro operates at scale (7+ years of operating history) providing multi-specialty care, insurance acceptance, larger medication formulary, and superior medical teams. If you have insurance, your cost for Ro's prescription options depends on your plan and can land below Mate's cash price, though the two are not the same kind of product. Mate is cash-pay only, about $540/year at its recorded $45/mo rate for Ignite, with no consultation, no prescription and no FDA review of the formula behind it. The value proposition overwhelmingly favors Ro through insurance acceptance, full-service care, credibility, and longevity. Mate makes sense only if avoiding a prescription is the point for you, not if you are looking for the cheaper option. Ro represents superior choice for vast majority of patients prioritizing quality, insurance benefits, and a proven platform.